Mark Stejbach

Mr. Mark P.
Stejbach is an Independent Non-Executive Director at Indivior Pharmaceuticals, Inc. and an Independent Non-Executive Director at Indivior Ltd. He is on the Board of Directors at Indivior Pharmaceuticals, Inc., Indivior Ltd. and Nirsum Laboratories, Inc. Mr. Stejbach was previously employed as an Independent Non-Executive Director by Flexion Therapeutics, Inc., a Chief Commercial Officer & Senior Vice President by Alkermes Plc, a Chief Commercial Officer by Tengion, Inc., a Principal by Biogen Idec MA, Inc., and a Vice President-Managed Care Marketing by Merck & Co., Inc. He also served on the board at Commonwealth National Fund, Inc. He received his undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from The Wharton School of the University of Pennsylvania.